Skip Navigation

JNCI Journal of the National Cancer Institute 2000 92(6):446-447; doi:10.1093/jnci/92.6.446
© 2000 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Benowitz, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benowitz, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 92, No. 6, 446-447, March 15, 2000
© 2000 Oxford University Press

NEWS

Wanted: Senior Citizens for Cancer Treatment Trials

Steve Benowitz

Cancer is primarily a disease of the elderly. Yet participation by the elderly in clinical trials is not nearly proportional to their representation in the population with cancer.

According to a Southwest Oncology Group study published Dec. 30 in the New England Journal of Medicine, 63% of all cancer patients are older than 65, but they only make up 25% of those enrolled in studies. The numbers get worse for breast cancer: The elderly make up 49% of breast cancer patients, but only 9% of patients 65 or older are in clinical trials for the disease.

Several years ago, federal rules mandated that clinical trials be made up of both women and minorities in proportion to the percentage of the population that has the disease. And in fact, the SWOG study found that these goals have been met.

. . . [Full Text of this Article]

Elderly Don’t Enroll

Specialized Trials


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?